EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) Change in Cash (2010 - 2026)

EyePoint (EYPT) posted Change in Cash of -$24.1 million for Q1 2026, down 188.49% sequentially from $27.2 million in Q4 2025, and down 65.74% YoY from -$70.4 million in Q1 2025.

Analysis

EyePoint (EYPT) Change in Cash (2010 - 2026) Analysis & Trends

EyePoint has reported Change in Cash for 17 years, with the latest figure at -$24.1 million in Q1 2026.

  • Quarterly Change in Cash fell 65.74% year-over-year to -$24.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.4 million (up 95.99% YoY) and the FY2025 annual result came in at $2.1 million, up 101.17% from the prior year.
  • Change in Cash slipped to -$24.1 million in Q1 2026 per EYPT's latest filing, from $27.2 million in the prior quarter.
  • Over five years, Change in Cash peaked at $148.2 million in Q4 2023 and troughed at -$180.2 million in Q2 2024.
  • A 5-year average of -$5.9 million and a median of -$6.8 million in 2022 frame the typical range for Change in Cash.
  • The sharpest annual moves came in 2023 and 2024: Change in Cash soared 631.23% in 2023, then sank 632.76% in 2024.
  • Over 5 years, Change in Cash stood at $20.3 million in 2022, then jumped by 631.23% to $148.2 million in 2023, then plunged by 86.59% to $19.9 million in 2024, then soared by 37.08% to $27.2 million in 2025, then plunged by 188.49% to -$24.1 million in 2026.
  • According to Business Quant data, Change in Cash over the past three periods registered -$24.1 million, $27.2 million, and $3.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 649.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.60 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -185.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 427.25 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -2.94 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.42 Mn
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00 32.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 32.75 Mn
Mar 31, 2026 -24.11 Mn
Dec 31, 2025 27.24 Mn
Sep 30, 2025 3.43 Mn
Jun 30, 2025 -14.02 Mn
Mar 31, 2025 -14.55 Mn
Dec 31, 2024 19.87 Mn
Sep 30, 2024 -10.94 Mn
Jun 30, 2024 -180.24 Mn
Mar 31, 2024 -10.25 Mn
Dec 31, 2023 148.23 Mn
Sep 30, 2023 -6.56 Mn
Jun 30, 2023 33.83 Mn
Mar 31, 2023 10.13 Mn
Dec 31, 2022 20.27 Mn
Sep 30, 2022 -6.77 Mn
Jun 30, 2022 -19.41 Mn
Mar 31, 2022 -77.05 Mn
Dec 31, 2021 58.88 Mn
Sep 30, 2021 -7.92 Mn